- Understanding metastatic breast cancer and its subtypes
- Initial hormone therapy for treatment of ER+/HER2- metastatic breast cancer
- Biomarkers: What they are and why we test for them
- Next hormone therapy ER+/HER2- metastatic breast cancer that progresses or stops responding
- A hypothetical example of a patient's treatment strategy
Educated Patient® Updates
in Metastatic Breast Cancer
Moderated by Lida A. Mina, M.D.
In this in-person discussion, we will dive into metastatic breast cancer (ESR1 mutation) insights including initial and subsequent treatments, understanding biomarkers, and reviewing an example treatment strategy. Don't miss this chance to engage with experts in Phoenix, AZ!
This event welcomes nurses, patients, survivors, and caregivers.
EVENT DETAILS
DATE & TIME
Thursday, December 18, 2025
5:30 - 6:00 PM: Registration Check-in & Refreshments
6:00 - 7:30 PM: Presentation & Q&A
LOCATION
Residence Inn by Marriott Phoenix Desert View at Mayo Clinic
5665 East Mayo Boulevard
Phoenix, Arizona, USA, 85054
*Across the street from Mayo Clinic
Moderator
Lida Mina, MD. Associate Professor , Hematology Oncology
Consultant | Women’s Cancer Program
Chair of the Breast and the Gynecology Disease Working Group
Mayo Clinic Cancer Center | Phoenix, AZ
AGENDA
CURE®'s Educated Patient® Updates is a 2-hour event designed to provide patients with the latest research and information on standards of cancer care and emerging therapies.
During this event, you’ll gain knowledge on topics such as:
You'll also find an extensive resource of cancer information featuring the latest breast cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on breast cancer.
Venue Location
Parking
Parking is free for all attendees.
Educated Patient® Updates in Metastatic Breast Cancer
WHEN
Thursday, December 18, 2025
QUESTIONS
Reach out to our events team (registration@curetoday.com) with any questions you may have.
REGISTER
Reserve your seat. This event is free to register and attend.
In partnership with:
